CC
TECH icon

Centiva Capital’s Bio-Techne TECH Stock Holding History

Centiva Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Buy
+225,000
New +$12.1M 0.14% 119
2025
Q3 		– Sell
-9,841
Closed -$506K – 1829
2025
Q2 		$506K Sell
9,841
-5,606
-36% -$282K 0.01% 948
2025
Q1 		$906K Buy
+15,447
New +$1.05M 0.03% 543
2024
Q3 		– Sell
-26,509
Closed -$1.9M – 2591
2024
Q2 		$1.9M Buy
26,509
+15,858
+149% +$1.17M 0.03% 448
2024
Q1 		$750K Buy
+10,651
New +$762K 0.02% 800
2023
Q4 		– Sell
-3,640
Closed -$248K – 2236
2023
Q3 		$248K Buy
3,640
+111
+3% +$8.77K 0.01% 1286
2023
Q2 		$288K Sell
3,529
-2,159
-38% -$174K 0.01% 1138
2023
Q1 		$422K Buy
+5,688
New +$438K 0.01% 907
2021
Q4 		– Sell
-4,084
Closed -$494K – 1536
2021
Q3 		$494K Sell
4,084
-7,624
-65% -$928K 0.03% 615
2021
Q2 		$1.32M Buy
+11,708
New +$1.23M 0.03% 459
2020
Q4 		– Sell
-9,396
Closed -$582K – 1100
2020
Q3 		$582K Buy
+9,396
New +$611K 0.04% 292
2020
Q2 		– Sell
-14,464
Closed -$686K – 812
2020
Q1 		$686K Buy
+14,464
New +$724K 0.03% 277

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Centiva Capital's TECH Position: Q2 2026 in Review

Centiva Capital opened a new position in Bio-Techne (TECH) in Q2 2026: 225,000 shares worth $15.9M. The stake represents 0.14% of the portfolio and ranks #119 among its holdings. This is a return to the name: Centiva Capital previously reported a position in TECH as recently as Q2 2025.

Centiva Capital first reported a position in TECH in Q1 2020 and has held it in 12 quarters since. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Centiva Capital held 225,000 shares of Bio-Techne worth $15.9M as of Q2 2026.
  • Bio-Techne was a new Centiva Capital position in Q2 2026.
  • Bio-Techne made up 0.14% of Centiva Capital's portfolio in Q2 2026, its #119 holding.
  • Centiva Capital first reported a position in Bio-Techne in Q1 2020 and has held it in 12 quarters since.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.